A new pill to lower blood sugar for people with type 2 diabetes was approved by the U.S. Food and Drug Administration on Friday. The drug, Rybelsus (semaglutide) is the first pill in a class of drugs called glucagon-like peptide (GLP-1) approved for use in the United States.
Comprehensive Review: Repatha (Evolocumab) and Its Role in Managing Elevated Lipoprotein(a)
Comprehensive Review: Repatha (Evolocumab) and Its Role in Managing Elevated Lipoprotein(a) 1. Introduction Repatha (evolocumab) is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). Approved by the FDA in 2015, Read more…
